Upcoming Allied Market Research
Bioanalytical Services Market

Bioanalytical Services Market: Global Opportunity Analysis and Industry Forecast, 2022-2029 Market

Report Code: A09807
Pages: NA
Nov 2022 | 1092 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Bioanalytical Services Market

Request Now !

Bioanalysis is a branch of analytical chemistry that deals with biological samples for analysis of measurement of biological molecules, DNA, and large molecules. The terms bioanalytical services and analytical services are usually used interchangeably in the healthcare industry. Bioanalytical services are specifically applied to toxicology, pharmacology studies, bioequivalence studies, along with pharmacokinetic and bioavailability studies in animals of humans. Bioanalytical services are applicable in every phase of drug development, from discovery to clinical development phases. Factor that differentiates   between analytical services and bioanalytical services is that bioanalytical services are employed to quantify the amount of drug present in a particular biological sample under study, whereas analytical services are used to check qualitative parameters of the drug molecules. Various bioanalytical platforms are being used to perform these services ranging from LC/MS, gas chromatography, ligand binding assays, immunoassays, cell-based assays, and mass spectrometry among others.

Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value (US$  Millions)

  Segments covered

  Test Type, Molecule Type , End-user, and Region

  Regions covered

North America (US and Canada), Europe (Germany, UK, France, Italy, and the Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and the Rest of Asia-Pacific), LAMEA (Latin America, Middle East, and Africa)

  Companies covered


  • ICON Plc
  • Covance, Inc.
  •  Charles River Laboratories International
  •   Bio-Rad Laboratories
  •   Eurofins Scientific
  •  WuXi AppTec


COVID-19  impact on industry

COVID-19 pandemic has forced many companies in the global bioanalytical services  market to halt their business operations to comply with the new government rules and regulations. This halt in operations directly impacts the revenue flow of the market players.

Production is at a standstill due to lockdowns imposed by governments around the world to reduce the exponential spread of the deadly virus. 

As per the estimation of the United Nations Conference on Trade and Development (UNCTAD), the COVID-19 outbreak could cause global FDI to shrink by 5 to 15%.

China is one of the world leaders in manufacturing and accounts for the highest contribution  to the global manufacturing services industry. 

With the COVID-19 crisis limiting mobility, decline in export activity, supply chain freezing, and shutting down of companies, the manufacturing sector faces massive economic loss. 

The pharmaceutical manufacturing sector is the only area where the demand can be expected to rise during the outbreak. However, the sector is also affected by supply chain and labor shortage problems throughout the globe.

Top impacting factors: market scenario analysis, trends, drivers, and impact analysis

Important growth drivers of the bioanalytical services market are use of bioanalytical services   in various industries such as pharmaceutical  & biotechnology  and increased investments by key players in R&D activities.

Increased investment in research and development- 

There is an ever increasing demand for bioanalytical services in the pharmaceutical and biotechnology industry. Comparatively higher costs and longer time duration required to conduct bioanalytical services in-house is a major factor driving demand for bioanalytical services. Due to this,  pharmaceutical and biotechnology companies are  outsourcing bioanalytical services to companies specializing in the domain. Also,  increase in incidence of chronic diseases and  due to this, increasing cost burden on economy due to these diseases  is creating a need  for new and personalized medicine and innovative drugs to be introduced in the market. This has led to increase in investment by biopharmaceutical companies in R&D and drug development, leading to higher demand for bioanalytical services in the global market. These factors combined with increasing number of players operating in the bioanalytical services market offering diversified and end-to-end portfolio of bioanalytical services fuel the growth of the global bioanalytical services market.

Need to create personalized and custom drugs and innovative medicine

The bioanalytical services market is facing increasing demand in the biotechnology and pharmaceutical industry. The demand is increasing due to the difficulties in conducting these services in-house. It has resulted in incurring higher costs and longer time, which has led to outsourcing of bioanalytical services by biotechnology and pharmaceutical companies. Furthermore, the rise in incidence of dangerous diseases and infections has resulted in undue economic cost pressure on hospitals and healthcare institutions across the world. Health expenditure among people is increasing rapidly for expensive cosmetic treatments and surgeries. Many research centers have identified the need to create personalized and custom drugs and innovative medicine as a part of bioanalytical services. Increased investment in drug development and R&D by biopharmaceutical companies has resulted in the growth of the bioanalytical services market

On the basis of molecule type, the bioanalytical testing services market is bifurcated into small molecule and large molecule. The small molecule segment held a lucrative market share in 2018. Most of the generic and branded drug compounds are belong to the small molecule category. Additionally, with the patent expiration of many blockbuster drugs, generic manufacturers are required to conduct and submit bioanalytical testing results. These factors primarily governed the growth of the segment in the forthcoming years.

On the other hand, large molecule segment is anticipated to exhibit healthy growth over the forecast period. This can be attributed to a rich pipeline of biologics or amino acid based molecules. Moreover, testing these molecules requires technical know-how with advanced analytical instruments. This infrastructure is available with bioanalytical services providers. Hence, outsourcing bioanalytical testing of these molecules is likely to be the prevailing trend over the forecast period.


Key segments covered:



   Test type

  • ADME (absorption, distribution, metabolism, and excretion)
  •  pharmacokinetic
  •  pharmacodynamics
  •  bioavailability
  •  bioequivalence

  Molecule type

  • small molecules
  •  large molecules
  •  vaccines

  End user 

  • pharmaceutical companies
  •  biotechnology companies,
  • contract research organizations



Key benefits of the report:

  • This study presents the analytical depiction of the bioanalytical services  market along with the current trends and future estimations to determine the future of the market
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of  bioanalytical services market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the bioanalytical services market growth scenario.

Bioanalytical Services Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Test type
  • ADME (absorption, distribution, metabolism, and excretion)  
  • pharmacokinetic  
  • pharmacodynamics
  •  bioavailability
  •  bioequivalence
By Molecule type
  • small molecules  
  • large molecules  
  • vaccines
By End user 
  • pharmaceutical companies  
  • biotechnology companies
  • contract research organizations
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players ICON Plc, Covance, Inc.,  Charles River Laboratories International, Bio-Rad Laboratories, Eurofins Scientific, WuXi AppTec, PPD, Inc., IQVIA, Syneos Health, Intertek Group Plc

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Bioanalytical Services Market

Start reading.
This Report and over 19,300+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers